Dear Colleagues,
We are publishing the first issue of our journal in 2026. In this issue, you will find a review article on the efficacy of vigabatrin, a drug no longer produced in our country, in infantile epileptic spasms. Unfortunately, every year, some drugs that have proven effective and play an important role in the treatment of epilepsy are discontinued, leaving us physicians and our patients in a difficult situation. I wanted to bring this problem to the forefront through this article. When it comes to human health, capitalism and the pursuit of profit must be kept under control, and the industry must also adhere to the ethical rules that many of us are bound by. The irresponsible withdrawal of a drug from the market should not be allowed.
In this issue and previous issues, studies on the psychological and emotional burden and social impacts of epilepsy on both patients and their caregivers have been frequently published. In this issue, a study on physical activity and epilepsy and another study on overprotection of individuals with epilepsy are particularly noteworthy. Archives of Epilepsy can be highlighted as a journal focusing on the socio-psychological aspects of epilepsy among journals publishing in the field of epilepsy.
I wish you pleasant reading.
S. Naz Yeni, M.D., Prof.
Editor-in-Chief
